Close Menu

Quite Personalized

Researchers developed a custom genetic drug just for one patient, eight-year-old Mila Makovec, who has a progressive neurological disorder, the New York Times reports. It adds, though, that this type of super personalized medicine opens up questions of how to assess the safety and efficacy of the treatment and how to pay for the treatment.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A tissue sample from the 1960s harbors a near-complete sample of HIV, IFLScience reports.

A new bill would reshape the US National Science Foundation to include a focus on technological development, according to Science.

The Food and Drug Administration's decision to halt a SARS-CoV-2 study has drawn criticism, according to Stat News.

In Genome Biology this week: features affecting gut microbiome and parasite patterns, cellular interactions in lung tumor microenvironment, and more.